Genomic profiling and PD-L1 expression of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CIBI308ALTER-C201 trial

被引：0
|
作者：
Xu, Qin [1 ]
Chen, Chuanben [2 ]
Sun, Yang [2 ]
Huang, Zhangzhou [2 ]
Lin, Yibin [2 ]
Liu, Jing [2 ]
Li, Li [2 ]
Li, Zirong [3 ]
Pan, Junping [2 ]
Chen, Ying [2 ]
机构：
[1] Fujian Med Univ Canc Hosp, Fujian Canc Hosp, Fuzhou, Peoples R China
[2] Fujian Canc Hosp, Fuzhou, Peoples R China
[3] Fujian Med Univ, Longyan Affiliated Hosp 1, Fuzhou, Peoples R China
来源：
GYNECOLOGIC ONCOLOGY | 2022年 / 166卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
035
引用
收藏
页码：S24 / S25
页数：2
相关论文
共 26 条
  • [1] Ribosomal protein S26 (RPS26) expression of advanced cervical cancer (CC) to predict response to programmed death-1 inhibitor combination therapy: A secondary analysis of the CIBI308ALTER-C201 trial
    Liu, Jing
    Li, Li
    Chen, Ying
    Song, Yanwen
    Luo, Lan
    Zhu, Shitao
    Xu, Qin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial
    Huang, Xin
    He, Minjun
    Peng, Hongyu
    Tong, Chongjie
    Liu, Zhimin
    Zhang, Xiaolong
    Shao, Yang
    Zhu, Dongqin
    Zhang, Junli
    Yin, Jiani C.
    Yang, Fan
    Lan, Chunyan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (05)
  • [3] Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial (vol 9, e002223, 2021)
    Huang, Xin
    He, Minjun
    Peng, Hongyu
    Tong, Chongjie
    Liu, Zhimin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)
  • [4] Genomic profiling of advanced cervical cancer to predict response to PD-1 inhibitor combination therapy: a secondary analysis of the CLAP trial
    Lan, Chunyan
    He, Minjun
    Peng, Hongyu
    Shao, Yang
    Zhu, Dongqin
    Zhang, Junli
    Yang, Fan
    Huang, Xin
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S28 - S28
  • [5] Multiparametric immune profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: an exploratory study of the CLAP trial
    Yin Wang
    Yuerong Lai
    Hongyu Peng
    Shumei Yan
    Zhimin Liu
    Chongjie Tong
    Xin Huang
    Clinical and Translational Oncology, 2023, 25 : 256 - 268
  • [6] Multiparametric immune profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: an exploratory study of the CLAP trial
    Wang, Yin
    Lai, Yuerong
    Peng, Hongyu
    Yan, Shumei
    Liu, Zhimin
    Tong, Chongjie
    Huang, Xin
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (01): : 256 - 268
  • [7] Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer
    Bari, Shahla
    Muzaffar, Jameel
    Chan, Austin
    Jain, Sanjay R.
    Haider, Ahmad M.
    Curry, Marjorie Adams
    Hostler, Christopher J.
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [8] The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy
    Zhang, Lifang
    Zhao, Yu
    Tu, Quanmei
    Xue, Xiangyang
    Zhu, Xueqiong
    Zhao, Kong-Nan
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (05) : 893 - 909
  • [9] Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer (vol 2019, 2989048, 2019)
    Bari, Shahla
    Muzaffar, Jameel
    Chan, Austin
    Jain, Sanjay R.
    Haider, Ahmad M.
    Curry, Marjorie Adams
    Hostler, Christopher J.
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [10] Compare the efficacy and safety of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) inhibitors for advanced non-small cell lung cancer: a Bayesian analysis
    Liang, Jiaqi
    Li, Ming
    Sui, Qihai
    Hu, Zhengyang
    Bian, Yunyi
    Huang, Yiwei
    Zhan, Cheng
    Jiang, Wei
    Wang, Qun
    Tan, Lijie
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 1302 - +
123